Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA

Watchlist Manager
Sun Pharmaceutical Industries Ltd Logo
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Watchlist
Price: 1 768.2 INR -0.61% Market Closed
Market Cap: 4.2T INR
Have any thoughts about
Sun Pharmaceutical Industries Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

29.3
Current
21.1
Median
13.7
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
29.3
=
Enterprise Value
4T INR
/
EBITDA
138B INR
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
27
2-Years Forward
EV/EBITDA
23.7
3-Years Forward
EV/EBITDA
21.5

See Also

Discover More